Clinical Trials Directory

Trials / Completed

CompletedNCT03143725

Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution

Open-label Study to Compare the Bioavailability of an Oral Wet Granulation Tablet of GLPG1972 Relative to an Oral Solution and to an Oral Direct Compression Tablet After Single-dose Intake in Healthy Subjects, and to Evaluate the Effect of Food on the Bioavailability of an Oral Wet Granulation Tablet.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Galapagos NV · Industry
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is a Phase I, randomized, open-label, cross-over study with 4 single-dose treatments of GLPG1972 to compare the bioavailability of the oral wet granulation (WG) tablet relative to an oral solution and to the oral direct compression (DC) tablet after single dose intake in healthy male subjects and to evaluate the effect of food on the bioavailability of the WG oral tablet.

Conditions

Interventions

TypeNameDescription
DRUGGLPG1972Oral administration of GLPG1972 in four different treatment conditions (Treatments A throug D)

Timeline

Start date
2017-04-14
Primary completion
2017-06-06
Completion
2017-06-06
First posted
2017-05-08
Last updated
2017-06-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03143725. Inclusion in this directory is not an endorsement.